Dengue Virus Inhibitors
Dengue virus inhibitors are a class of chemical compounds that specifically target various stages of the dengue virus (DENV) life cycle, blocking its ability to replicate and propagate within host cells. The dengue virus is a flavivirus, consisting of a single-stranded RNA genome enclosed by a protein capsid and surrounded by an envelope. The viral life cycle involves several critical steps, including viral attachment, entry, replication of the viral RNA, assembly of new viral particles, and their release from the host cell. Inhibitors of the dengue virus can interfere with any of these stages, effectively disrupting the virus's ability to complete its replication cycle. For example, entry inhibitors prevent the virus from binding to or entering host cells, while protease inhibitors block the processing of viral polyproteins necessary for viral assembly.
The mechanisms of action for dengue virus inhibitors vary depending on the specific target within the viral life cycle. Some inhibitors may block the viral envelope proteins, such as E protein, which mediate the fusion of the viral membrane with the host cell membrane, thus preventing the virus from entering host cells. Other inhibitors might target viral enzymes like NS3 protease or NS5 polymerase, which are essential for processing viral RNA and protein synthesis. By inhibiting these viral components, the compounds prevent the virus from replicating its genome or assembling new viral particles. These inhibitors provide valuable tools for studying the molecular biology of dengue virus replication, helping researchers understand how the virus interacts with host cell machinery and the specific viral structures that are crucial for its life cycle.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sofosbuvir | 1190307-88-0 | sc-482362 | 25 mg | $146.00 | 1 | |
Sofosbuvir is a direct inhibitor of Dengue Virus, targeting the viral RNA-dependent RNA polymerase (RdRp). By inhibiting RdRp, Sofosbuvir interferes with viral replication, preventing the synthesis of viral RNA and inhibiting Dengue Virus propagation. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin is a direct inhibitor of Dengue Virus, exerting its antiviral effects by inhibiting viral RNA synthesis. Ribavirin is known to interfere with the viral RdRp and disrupt the replication process, thereby suppressing Dengue Virus replication. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Ivermectin is a direct inhibitor of Dengue Virus, with antiviral effects linked to the inhibition of nuclear import. It interferes with the interaction between viral proteins and host factors, preventing the nuclear translocation essential for viral replication. This disruption in the viral life cycle contributes to the inhibition of Dengue Virus infection. | ||||||
Nitazoxanide | 55981-09-4 | sc-212397 | 10 mg | $124.00 | 1 | |
Nitazoxanide is a direct inhibitor of Dengue Virus, with antiviral activity attributed to the inhibition of viral protein maturation. It interferes with viral protease activity, affecting the processing of viral polyproteins and disrupting Dengue Virus replication. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-MA is an indirect inhibitor of Dengue Virus, targeting the autophagy pathway. By inhibiting the formation of autophagosomes, 3-Methyladenine disrupts the cellular process exploited by Dengue Virus for its replication. This inhibition impedes the virus's ability to utilize autophagy for its benefit, providing a potential avenue for controlling Dengue Virus infection. | ||||||
Nelfinavir | 159989-64-7 | sc-507314 | 10 mg | $168.00 | ||
Nelfinavir is a direct inhibitor of Dengue Virus, known for its activity against viral proteases. By inhibiting viral protease function, Nelfinavir disrupts the cleavage of viral polyproteins, interfering with the maturation of Dengue Virus particles and suppressing viral replication. | ||||||
Celgosivir | 121104-96-9 | sc-488385 sc-488385A sc-488385B | 5 mg 25 mg 100 mg | $525.00 $902.00 $2700.00 | ||
Celgosivir is a direct inhibitor of Dengue Virus, targeting the viral enzyme glycoside hydrolase. This inhibition interferes with the glycosylation process essential for the synthesis of viral proteins, disrupting the viral life cycle and inhibiting Dengue Virus replication. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is an indirect inhibitor of Dengue Virus, affecting endosomal acidification. By raising the pH within endosomes, Chloroquine impairs viral entry and prevents the release of the viral genome into the host cell. This disruption in the viral life cycle contributes to the inhibition of Dengue Virus infection. | ||||||